ACC 2021: Sacubitril-Valsartan Fails to Outperform Ramipril in Post-Myocardial Infarction Heart Failure Patients
Trends suggesting a benefit with the combination largely failed to reach significance
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.